Yahoo India Web Search

Search results

1. pubmed.ncbi.nlm.nih.gov › 29910549Experience with β-D-Glucan Assay in the Management of ...

   pubmed.ncbi.nlm.nih.gov › 29910549

   Background: The (1,3)-β-D-glucan assay (BDG) is recommended for the early diagnosis of invasive candidiasis (IC). Methods: Records of 154 critically ill adults with suspected IC, on whom BDG was done, were analyzed.

   • Author: Nitin Bansal, Ram Gopalakrishnan, Nandini Sethuraman, Nagarajan Ramakrishnan, P Senthur Nambi, D Sur...

   • Publish Year: 2018

2. www.ncbi.nlm.nih.gov › pmc › articlesExperience with β-D-Glucan Assay in the Management of ...

   www.ncbi.nlm.nih.gov › pmc › articles

   BDG assay has been utilized in the early diagnosis of IC/candidemia and also has a high negative predictive value (NPV) and therefore can be utilized for stopping empirical antifungal therapy. The BDG assay has recently been introduced in India and the clinical efficacy data of BDG in Indian ICUs are lacking.

   • Author: Nitin Bansal, Ram Gopalakrishnan, Nandini Sethuraman, Nagarajan Ramakrishnan, P Senthur Nambi, D Sur...
   • DOI: 10.4103/ijccm.IJCCM_4_18

   • Publish Year: 2018
   • Published: 2018/05

3. www.ncbi.nlm.nih.gov › pmc › articlesβ- d -Glucan Testing Is Important for Diagnosis of Invasive ...

   www.ncbi.nlm.nih.gov › pmc › articles

   An abundant cell wall polysaccharide, (1-3)-β- d -glucan (BDG) is found in most fungi, with the notable exception of the cryptococci, the zygomycetes, and Blastomyces dermatitidis, which either lack the glucan entirely or produce it at minimal levels.

   • Author: Elitza S. Theel, Christopher D. Doern

   • Publish Year: 2013

4. www.researchgate.net › publication › 325199266Experience with β-D-Glucan Assay in the Management of ...

   www.researchgate.net › publication › 325199266

   May 1, 2018 · Serum beta-D-glucan (BDG) was done only in 32 patients of the 114 (35.3%); among those who were tested, 5 (15.6%) had a BDG value of less than 80 pg/mL despite having Candida BSI. Fluconazole...

5. www.ncbi.nlm.nih.gov › pmc › articlesUtility of (1–3)-β-d-Glucan Testing for Diagnostics and ...

   www.ncbi.nlm.nih.gov › pmc › articles

   Mar 1, 2014 · Our data suggest that (1-3)-β- d -glucan (BDG) using cerebrospinal fluid (CSF) is a highly sensitive test for diagnosis of fungal meningitis in the outbreak of fungal meningitis and other infections. BDG levels in serially collected CSF demonstrated that BDG may correlate with clinical response.

   • Author: Anastasia P. Litvintseva, Mark D. Lindsley, Lalitha Gade, Rachel Smith, Tom Chiller, Jennifer L. Lyo...
   • DOI: 10.1093/cid/cit808

   • Publish Year: 2014
   • Publication: Clin Infect Dis. 2014 Mar 1; 58(5): 622-630.

6. www.researchgate.net › publication › 320201061Experience with β-d-Glucan Assay for Diagnosis of Invasive ...

   www.researchgate.net › publication › 320201061

   Oct 1, 2017 · Background β-d-Glucan assay (BDG) has been recently introduced in India and is recommended for the early diagnosis of invasive candidiasis (IC), but there are a number of factors (eg β-lactam...

7. People also ask

   What is a BDG test?

   • The concept of the (1,3)-β- d -glucan (BDG) test is highly desirable; it provides a noninvasive test method which is designed to diagnose invasive fungal infections (IFIs). As more patients experience prolonged immunocompromised periods, IFIs have become increasingly common.

   β-d-Glucan Testing Is Important for Diagnosis of Invasive Fungal

   www.ncbi.nlm.nih.gov/pmc/articles/PMC3889722/

   See all results for this question

   What does BDG stand for?

   • (1,3)-β- d -glucan (BDG) is a glucose polymer that is part of the fungal cell wall [ 9 ]. The Fungitell assay (Associates of Cape Cod, Inc, Falmouth, Massachusetts) has been approved by the US Food and Drug Administration (FDA) for detection of BDG in human serum and used in diagnosis of fungal infections [ 10 – 12 ].

   Utility of (1–3)-β-d-Glucan Testing for Diagnostics and Monitoring

   www.ncbi.nlm.nih.gov/pmc/articles/PMC4047277/

   See all results for this question

   Can BDG be detected in alternative invasive Laboratory Practices for IFI diagnosis?

   • As with testing for other fungal antigens, detection of BDG in alternative, invasively collected specimens (i.e., BAL fluid and cerebrospinal fluid [CSF]) has the potential to further enhance the sensitivity of standard laboratory practices for IFI diagnosis. Detailed studies evaluating this testing option, however, are still needed.

   β-d-Glucan Testing Is Important for Diagnosis of Invasive Fungal

   www.ncbi.nlm.nih.gov/pmc/articles/PMC3889722/

   See all results for this question

   Is BDG antigenemia a useful diagnostic tool?

   • Conclusions. Detection of BDG antigenemia can be a useful diagnostic tool if used in the proper clinical setting (i.e., immunosuppressed, neutropenic patients) by a provider knowledgeable of both the advantages and limitations of the assay as applied to each individual patient.

   β-d-Glucan Testing Is Important for Diagnosis of Invasive Fungal

   www.ncbi.nlm.nih.gov/pmc/articles/PMC3889722/

   See all results for this question

8. bmcinfectdis.biomedcentral.com › articles › 10Development of a clinical risk score for the prediction of

   bmcinfectdis.biomedcentral.com › articles › 10

   • Cached

   2 days ago · Background The performance and availability of invasive and non-invasive investigations for the diagnosis of Pneumocystis jirovecii pneumonia (PCP) vary across clinical settings. Estimating the pre-test probability of PCP is essential to the optimal selection and interpretation of diagnostic tests, such as the 1,3-β-D-glucan assay (BDG), for the prioritization of bronchoscopy, and to guide empiric treatment decisions. We aimed to develop a multivariable risk score to estimate the pre-test ...